GEP20084494B - New heterocyclic carboxylic acid amide derivatives - Google Patents
New heterocyclic carboxylic acid amide derivativesInfo
- Publication number
- GEP20084494B GEP20084494B GEAP20059896A GEAP2005009896A GEP20084494B GE P20084494 B GEP20084494 B GE P20084494B GE AP20059896 A GEAP20059896 A GE AP20059896A GE AP2005009896 A GEAP2005009896 A GE AP2005009896A GE P20084494 B GEP20084494 B GE P20084494B
- Authority
- GE
- Georgia
- Prior art keywords
- carboxylic acid
- acid amide
- amide derivatives
- heterocyclic carboxylic
- new heterocyclic
- Prior art date
Links
- -1 heterocyclic carboxylic acid Chemical class 0.000 title abstract 2
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0401527A HU227119B1 (en) | 2004-07-29 | 2004-07-29 | Indole and benzimidazole carboxylic acid amide derivatives and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP20084494B true GEP20084494B (en) | 2008-09-25 |
Family
ID=89985412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP20059896A GEP20084494B (en) | 2004-07-29 | 2005-07-21 | New heterocyclic carboxylic acid amide derivatives |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20080300276A1 (https=) |
| EP (1) | EP1771437A1 (https=) |
| JP (1) | JP2008508251A (https=) |
| KR (1) | KR20070038503A (https=) |
| CN (1) | CN1989126A (https=) |
| AP (1) | AP2076A (https=) |
| AU (1) | AU2005266164A1 (https=) |
| BR (1) | BRPI0513900A (https=) |
| CA (1) | CA2574169A1 (https=) |
| EA (1) | EA011635B1 (https=) |
| GE (1) | GEP20084494B (https=) |
| HU (1) | HU227119B1 (https=) |
| IL (1) | IL179483A0 (https=) |
| MA (1) | MA28818B1 (https=) |
| MX (1) | MX2007001049A (https=) |
| NO (1) | NO20071112L (https=) |
| TN (1) | TNSN07014A1 (https=) |
| UA (1) | UA88643C2 (https=) |
| WO (1) | WO2006010969A1 (https=) |
| ZA (1) | ZA200700329B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2520567A3 (en) | 2006-02-23 | 2012-12-12 | Shionogi & Co., Ltd. | Nitrogen-containing heterocycle derivatives substituted with cyclic group |
| MX2012008721A (es) | 2010-02-16 | 2012-08-17 | Pfizer | (r)-4-((4-((4-(tetrahidrofuran-3-iloxi)benzo[d]isoxazol-3-iloxi)m etil) tetrahidro-2h-piran-4-ol, un agonista pacial de receptores 5-ht4. |
| KR102043337B1 (ko) | 2014-08-28 | 2019-11-11 | 아셰뉴론 에스아 | 글리코시다제 저해제 |
| EP3389658B1 (en) * | 2015-12-18 | 2020-11-25 | Merck Sharp & Dohme Corp. | Glycosidase inhibitors and uses thereof |
| CA3014572C (en) | 2016-02-25 | 2023-10-03 | Asceneuron S.A. | Acid addition salts of piperazine derivatives |
| KR20180132629A (ko) | 2016-02-25 | 2018-12-12 | 아셰뉴론 에스아 | 글리코시다제 저해제 |
| US11261183B2 (en) | 2016-02-25 | 2022-03-01 | Asceneuron Sa | Sulfoximine glycosidase inhibitors |
| AU2017222964B2 (en) | 2016-02-25 | 2020-01-02 | Asceneuron S. A. | Glycosidase inhibitors |
| US11213525B2 (en) | 2017-08-24 | 2022-01-04 | Asceneuron Sa | Linear glycosidase inhibitors |
| WO2020039029A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Spiro compounds as glycosidase inhibitors |
| WO2020039027A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Pyrrolidine glycosidase inhibitors |
| WO2020039028A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Tetrahydro-benzoazepine glycosidase inhibitors |
| JP7407171B2 (ja) | 2018-08-22 | 2023-12-28 | エースニューロン・ソシエテ・アノニム | グリコシダーゼ阻害剤として有用なピペラジン誘導体のコハク酸付加塩及びフマル酸付加塩 |
| CN113906033B (zh) | 2019-06-04 | 2024-04-02 | 勃林格殷格翰国际有限公司 | 咪唑并吡嗪衍生物及其作为药剂的用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU227197B1 (en) * | 2000-10-24 | 2010-10-28 | Richter Gedeon Nyrt | Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them |
-
2004
- 2004-07-29 HU HU0401527A patent/HU227119B1/hu unknown
-
2005
- 2005-07-21 CA CA002574169A patent/CA2574169A1/en not_active Abandoned
- 2005-07-21 AP AP2006003843A patent/AP2076A/en active
- 2005-07-21 CN CNA2005800241844A patent/CN1989126A/zh active Pending
- 2005-07-21 EA EA200700360A patent/EA011635B1/ru not_active IP Right Cessation
- 2005-07-21 KR KR1020077000266A patent/KR20070038503A/ko not_active Withdrawn
- 2005-07-21 UA UAA200702172A patent/UA88643C2/ru unknown
- 2005-07-21 BR BRPI0513900-7A patent/BRPI0513900A/pt not_active IP Right Cessation
- 2005-07-21 US US11/658,486 patent/US20080300276A1/en not_active Abandoned
- 2005-07-21 MX MX2007001049A patent/MX2007001049A/es not_active Application Discontinuation
- 2005-07-21 GE GEAP20059896A patent/GEP20084494B/en unknown
- 2005-07-21 WO PCT/HU2005/000082 patent/WO2006010969A1/en not_active Ceased
- 2005-07-21 JP JP2007523164A patent/JP2008508251A/ja not_active Withdrawn
- 2005-07-21 AU AU2005266164A patent/AU2005266164A1/en not_active Abandoned
- 2005-07-21 EP EP05764183A patent/EP1771437A1/en not_active Withdrawn
-
2006
- 2006-11-22 IL IL179483A patent/IL179483A0/en unknown
-
2007
- 2007-01-11 ZA ZA200700329A patent/ZA200700329B/en unknown
- 2007-01-17 TN TNP2007000014A patent/TNSN07014A1/en unknown
- 2007-02-22 MA MA29705A patent/MA28818B1/fr unknown
- 2007-02-27 NO NO20071112A patent/NO20071112L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008508251A (ja) | 2008-03-21 |
| HU227119B1 (en) | 2010-07-28 |
| ZA200700329B (en) | 2008-05-28 |
| HUP0401527A2 (en) | 2006-01-30 |
| KR20070038503A (ko) | 2007-04-10 |
| HU0401527D0 (en) | 2004-09-28 |
| BRPI0513900A (pt) | 2008-05-20 |
| CN1989126A (zh) | 2007-06-27 |
| UA88643C2 (ru) | 2009-11-10 |
| IL179483A0 (en) | 2007-05-15 |
| TNSN07014A1 (en) | 2008-06-02 |
| CA2574169A1 (en) | 2006-02-02 |
| EP1771437A1 (en) | 2007-04-11 |
| NO20071112L (no) | 2007-02-27 |
| MX2007001049A (es) | 2007-04-16 |
| AP2006003843A0 (en) | 2006-12-31 |
| WO2006010969A8 (en) | 2006-08-31 |
| US20080300276A1 (en) | 2008-12-04 |
| MA28818B1 (fr) | 2007-08-01 |
| EA200700360A1 (ru) | 2007-06-29 |
| AP2076A (en) | 2009-12-17 |
| WO2006010969A1 (en) | 2006-02-02 |
| AU2005266164A1 (en) | 2006-02-02 |
| EA011635B1 (ru) | 2009-04-28 |
| HUP0401527A3 (en) | 2008-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY136959A (en) | Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof | |
| TNSN07195A1 (en) | Potentiators of glutamate receptors | |
| ES2338590T3 (es) | Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos. | |
| DK1776377T3 (da) | Nyt steroid til FXR | |
| TNSN07325A1 (en) | Pgd2 receptor antagonists for the treatment of inflammatory diseases | |
| NO20092762L (no) | 2-aza-bicyklo[3.1.0]heksanderivater | |
| MY143581A (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
| IL177291A0 (en) | Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists | |
| GEP20084494B (en) | New heterocyclic carboxylic acid amide derivatives | |
| TW200637822A (en) | Process for the preparation of a 2-pyridylethylcarboxamide derivative | |
| MX2010008713A (es) | Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii. | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| TW200720260A (en) | Prokineticin 1 receptor antagonists | |
| TW200633981A (en) | Process for the preparation of a 2-ethylaminopyridine derivative | |
| TW200716566A (en) | Prokineticin 2 receptor antagonists | |
| TNSN07006A1 (en) | Novel heterocyclic compounds | |
| IL180312A0 (en) | Process for preparing carboxamide pyridine derivatives used as intermediates in the synthesis of nk-1 recepor antagonists | |
| EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина | |
| NO20081529L (no) | Naftyridinderivater | |
| MY140858A (en) | Ampa receptor potentiators | |
| ZA200804858B (en) | Sulfoximine derivatives as p38 map kinase inhibitors | |
| IL173582A0 (en) | A process for the preparation of phenyltetrazole derivatives | |
| SI1893597T1 (sl) | Ojaäśevalci ampa receptorja | |
| WO2006109146A3 (en) | Novel heterocyclic derivatives | |
| WO2006126074A3 (en) | Heterocyclic derivatives |